Search hospitals > Oklahoma > Oklahoma City
Oklahoma Medical Research Foundation
Claim this profileOklahoma City, Oklahoma 73104
Global Leader in Systemic Lupus Erythematosus
Global Leader in Lupus
Conducts research for Multiple Sclerosis
Conducts research for Primary Lateral Sclerosis
Conducts research for Coronary Artery Disease
154 reported clinical trials
6 medical researchers
Summary
Oklahoma Medical Research Foundation is a medical facility located in Oklahoma City, Oklahoma. This center is recognized for care of Systemic Lupus Erythematosus, Lupus, Multiple Sclerosis, Primary Lateral Sclerosis, Coronary Artery Disease and other specialties. Oklahoma Medical Research Foundation is involved with conducting 154 clinical trials across 131 conditions. There are 6 research doctors associated with this hospital, such as Gabriel Pardo, Cristina Arriens, MD, MSCS, Judith A. James, MD, PhD, and Christina Arriens, MD.Area of expertise
1Systemic Lupus Erythematosus
Global LeaderANA positive
anti-dsDNA positive
anti-Sm positive
2Lupus
Global LeaderANA positive
anti-dsDNA positive
anti-Smith positive
Top PIs
Gabriel PardoOklahoma Medical Research Foundation5 years of reported clinical research
Studies Multiple Sclerosis
Studies Primary Lateral Sclerosis
9 reported clinical trials
17 drugs studied
Cristina Arriens, MD, MSCSOklahoma Medical Research Foundation7 years of reported clinical research
Studies Lupus
Studies Cutaneous Lupus Erythematosus
4 reported clinical trials
8 drugs studied
Judith A. James, MD, PhDOklahoma Medical Research Foundation: Arthritis and Clinical Immunology Research Program7 years of reported clinical research
Studies Lupus
Studies Coronavirus
2 reported clinical trials
5 drugs studied
Christina Arriens, MDOklahoma Medical Research Foundation2 years of reported clinical research
Studies Lupus
2 reported clinical trials
7 drugs studied
Clinical Trials running at Oklahoma Medical Research Foundation
Multiple Sclerosis
Systemic Lupus Erythematosus
Lupus
Primary Lateral Sclerosis
Sarcopenia
Shingles
Neuromyelitis Optica
Neuromyelitis Optica (NMO)
Ocrelizumab
for Multiple Sclerosis
This trial is testing if patients with early relapsing multiple sclerosis can stop taking Ocrelizumab after initial treatment without their disease getting worse. Ocrelizumab is a medication given through an IV that helps manage multiple sclerosis by reducing harmful immune cells. The study will monitor patients for new disease activity over several years.
Recruiting2 awards Phase 4
Frexalimab
for Multiple Sclerosis
The study is evaluating the efficacy and safety of Frexalimab in patients with non-relapsing, secondary progressive MS. The primary objective is to determine whether Frexalimab can delay disability progression compared to placebo.
Recruiting1 award Phase 312 criteria
Frexalimab
for Multiple Sclerosis
The study is evaluating whether Frexalimab performs better than the existing MS medication, Teriflunomide, at reducing the number of relapses in patients with relapsing forms of multiple sclerosis.
Recruiting1 award Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Oklahoma Medical Research Foundation?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.